{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:43:50Z","timestamp":1778561030525,"version":"3.51.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Prenatal and perinatal infections and inflammation appear to associated with the development of retinopathy of prematurity (ROP). In this study, we evaluated whether inflammatory mediators in amniotic fluid (AF) retrieved during cesarean delivery influence the development of ROP in very low birth weight (VLBW) infants.<\/jats:p>\n          <jats:p>This retrospective study included 16 and 32 VLBW infants who did and did not develop any stage of ROP, respectively. Each infant with ROP was matched with 2 infants without ROP based on days of ventilation care, gestational age, and birth weight. AF was obtained during cesarean delivery, and the levels of intra-amniotic inflammatory mediators such as interleukin (IL)-1\u03b2, IL-2, IL-6, IL-8, IL-10, matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and tumor necrosis factor (TNF)-\u03b1 were measured using a Human Magnetic Luminex assay (R&amp;D Systems, Minneapolis, MN). The differences in the levels of inflammatory mediators according to the presence or absence of ROP were compared.<\/jats:p>\n          <jats:p>In patients who developed ROP, the level of MMP-2 in the AF was significantly increased (<jats:italic toggle=\"yes\">P<\/jats:italic> = .011), whereas the levels of IL-10 and TNF-\u03b1 were significantly decreased (<jats:italic toggle=\"yes\">P<\/jats:italic> = .028 and .046, respectively) compared with those in infants who did not develop ROP. The levels of the other mediators were not significantly different between the 2 groups. Multivariate regression analysis showed that MMP-2 was a risk factor for the development of ROP (odds ratio, 2.445; 95% confidence interval, 1.170-5.106; <jats:italic toggle=\"yes\">P<\/jats:italic> = .017).<\/jats:p>\n          <jats:p>The concentration of MMP-2 in AF is an independent factor in the development of ROP. Further studies are needed to determine whether the levels of inflammatory mediators in AF affect the ROP severity.<\/jats:p>","DOI":"10.1097\/md.0000000000029368","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T12:20:44Z","timestamp":1657282844000},"page":"e29368","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["The association between amniotic fluid-derived inflammatory mediators and the risk of retinopathy of prematurity"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9501-9892","authenticated-orcid":false,"given":"Ji Hye","family":"Jang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Keimyung University School of Medicine, Daegu, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Gon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Keimyung University School of Medicine, Daegu, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Hyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Keimyung University School of Medicine, Daegu, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Gon","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keimyung University School of Medicine, Daegu, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8953-3695","authenticated-orcid":false,"given":"Jae Hyun","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Keimyung University School of Medicine, Daegu, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","article-title":"Retinopathy of prematurity.","volume":"10","author":"Chen","year":"2007","journal-title":"Angiogenesis"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity.","volume":"367","author":"Hartnett","year":"2012","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1038\/onc.2008.304","article-title":"Regulation of angiogenesis: apoptotic cues from the ECM.","volume":"27","author":"Cheresh","year":"2008","journal-title":"Oncogene"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.3390\/ijms21197413","article-title":"Pericyte-endothelial interactions in the retinal microvasculatur.","volume":"21","author":"Huang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-3-319-89512-3_16","article-title":"Control of blood vessel formation by Notch signaling.","volume":"1066","author":"Tetzlaff","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.earlhumdev.2008.12.010","article-title":"Immaturity, perinatal inflammation, and retinopathy of prematurity: a multi-hit hypothesis.","volume":"85","author":"Dammann","year":"2009","journal-title":"Early Hum Dev"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.siny.2011.08.007","article-title":"Perinatal infection, inflammation, and retinopathy of prematurity.","volume":"17","author":"Lee","year":"2012","journal-title":"Semin Fetal Neonatal Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1167\/iovs.10-6279","article-title":"Assessment of the contribution of cytokine plasma levels to detect retinopathy of prematurity in very low birth weight infants.","volume":"52","author":"Silveira","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1167\/iovs.19-27258","article-title":"Immune and inflammatory proteins in cord blood as predictive biomarkers of retinopathy of prematurity in preterm infants.","volume":"60","author":"Park","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1167\/iovs.13-11837","article-title":"The relationship between cord blood cytokine levels and perinatal factors and retinopathy of prematurity: a gestational age-matched case-control study.","volume":"54","author":"Woo","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"313","DOI":"10.12891\/ceog16292014","article-title":"Biological markers in cord blood for prediction of bronchopulmonary dysplasia in premature infants.","volume":"41","author":"Tian","year":"2014","journal-title":"Clin Exp Obstet Gynecol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"89.e1","DOI":"10.1016\/j.ajog.2020.12.1214","article-title":"Amniotic fluid interleukin 6 and interleukin 8 are superior predictors of fetal lung injury compared with maternal or fetal plasma cytokines or placental histopathology in a nonhuman primate model.","volume":"225","author":"McCartney","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3109\/14767058.2011.587918","article-title":"Correlation of midtrimester amniotic fluid cytokine concentrations with adverse pregnancy outcome in terms of spontaneous abortion, preterm birth, and preeclampsia.","volume":"25","author":"Bamberg","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10654-017-0325-0","article-title":"Case-control matching: effects, misconceptions, and recommendations.","volume":"33","author":"Mansournia","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/peds.2012-2996","article-title":"Screening examination of premature infants for retinopathy of prematurity.","volume":"131","author":"Fierson","year":"2013","journal-title":"Pediatrics"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited.","volume":"123","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R17-20250504","first-page":"233","article-title":"Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial.","volume":"102","author":"Good","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.clp.2010.02.003","article-title":"Diagnosis and management of clinical chorioamnionitis.","volume":"37","author":"Tita","year":"2010","journal-title":"Clin Perinatol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1167\/iovs.61.5.42","article-title":"Inflammatory and angiogenic mediators in amniotic fluid are associated with the development of retinopathy of prematurity in preterm infants.","volume":"61","author":"Woo","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-20250504","first-page":"45","article-title":"Risks of third-trimester amniocentesis.","volume":"53","author":"Zalud","year":"2008","journal-title":"J Reprod Med"},{"key":"R21-20250504","first-page":"48","article-title":"Need for urgent delivery after third-trimester amniocentesis.","volume":"95","author":"Stark","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R22-20250504","first-page":"255","article-title":"Complications of third-trimester amniocentesis using continuous ultrasound guidance.","volume":"99","author":"Gordon","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.bmc.2007.01.011","article-title":"Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.","volume":"15","author":"Verma","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1189\/jlb.0607338","article-title":"Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation.","volume":"82","author":"Van Lint","year":"2007","journal-title":"J Leukoc Biol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fonc.2019.01370","article-title":"Role of matrix metalloproteinases in angiogenesis and cancer.","volume":"9","author":"Quintero-Fabi\u00e1n","year":"2019","journal-title":"Front Oncol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/0973-1482.157337","article-title":"Seesaw of matrix metalloproteinases (MMPs).","volume":"12","author":"Kapoor","year":"2016","journal-title":"J Cancer Res Ther"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.biochi.2019.07.019","article-title":"Matrix metalloproteinase-2: not (just) a \u201chero\u201d of the past.","volume":"166","author":"Henriet","year":"2019","journal-title":"Biochimie"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/01.ATV.0000209518.58252.17","article-title":"Pericellular proteases in angiogenesis and vasculogenesis.","volume":"26","author":"van Hinsbergh","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s12035-017-0386-9","article-title":"IGF-1R regulates the extracellular level of active MMP-2, pathological neovascularization, and functionality in retinas of OIR mouse model.","volume":"55","author":"Lorenc","year":"2018","journal-title":"Mol Neurobiol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.pmbts.2017.02.004","article-title":"Regulation of matrix metalloproteinase in the pathogenesis of diabetic retinopathy.","volume":"148","author":"Kowluru","year":"2017","journal-title":"Prog Mol Biol Transl Sci"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-94-024-0921-5_5","article-title":"Regulation of interleukin-10 expression.","volume":"941","author":"Rutz","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"e20190418","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10.","volume":"217","author":"Saraiva","year":"2020","journal-title":"J Exp Med"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","article-title":"TNF alpha and the TNF receptor superfamily: structure-function relationship(s).","volume":"50","author":"Idriss","year":"2000","journal-title":"Microsc Res Tech"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2217\/fon.10.155","article-title":"TNF: a tumor-suppressing factor or a tumor-promoting factor?","volume":"6","author":"Balkwill","year":"2010","journal-title":"Future Oncol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2567.2008.02933.x","article-title":"Anti-inflammatory effects of tumour necrosis factor (TNF)-alpha are mediated via TNF-R2 (p75) in tolerogenic transforming growth factor-beta-treated antigen-presenting cells.","volume":"127","author":"Masli","year":"2009","journal-title":"Immunol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.4049\/jimmunol.175.8.5024","article-title":"Paradoxical anti-inflammatory actions of TNF-alpha: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells.","volume":"175","author":"Zakharova","year":"2005","journal-title":"J Immunol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1167\/iovs.17-21931","article-title":"Systemic inflammation-associated proteins and retinopathy of prematurity in infants born before the 28th week of gestation.","volume":"58","author":"Holm","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:05:08Z","timestamp":1746331508000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":37,"journal-issue":{"issue":"27","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029368","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]}}}